HEL · REG1V.HE
Revenio Group Oyj
€10.38-€0.02 (-0.19%)
Revenio Group Oyj’s quoted price sits in the lower half of its reported 52-week range, 58.15% below the high.
Loading market information…
HEL · TTALO.HE · EUR
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 04:29 PM UTC. Cached market data; not a live quote.
One-year closing-price history · EUR. Historical prices are not a forecast.
Terveystalo Oyj’s quoted price sits in the lower half of its reported 52-week range, 42.03% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Terveystalo Oyj’s forward annual dividend is €0.64 per share, paid semi-annual. The forward yield is 10.6% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Terveystalo Oyj’s next earnings report is currently expected on Feb 12, 2027, with estimated earnings per share of €0.22. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Terveystalo Oyj’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Terveystalo Oyj, based in Helsinki, Finland, stands as a leading provider of healthcare services, with a strong focus on occupational health for businesses across the country. Its extensive service portfolio covers general practitioner consultations, specialized medical care, diagnostic procedures, outpatient and day surgery, and a full spectrum of dental and oral health services. The company further extends its offerings to include laboratory and imaging capabilities, wellbeing programs, child welfare services, and various healthcare outsourcing and staffing solutions. Terveystalo also provides modern digital healthcare platforms and engages in clinical research. Serving a diverse clientele, its customers range from private individuals and corporate entities to insurance companies and the public sector. The company maintains a substantial physical presence, operating 360 clinics throughout Finland, which include 18 hospital units, 38 dental clinics, and 73 Rela hierojat massage therapy units. Terveystalo Oyj was established in 2001.
Latest available per-share figures in EUR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:52 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q2 2025 | Jul 17, 2025 | €0.17+10.89% vs estimate | €321.50M+11.15% vs estimate |
|---|
| Q1 2025 | Apr 25, 2025 | €0.28+21.74% vs estimate | €346.90M-0.16% vs estimate |
|---|
| Q4 2024 | Feb 14, 2025 | €0.21+10.53% vs estimate | €353.90M-1.83% vs estimate |
|---|
KEEP COMPARING
€10.38-€0.02 (-0.19%)
Revenio Group Oyj’s quoted price sits in the lower half of its reported 52-week range, 58.15% below the high.
€8.43-€0.16 (-1.86%)
Pihlajalinna Oyj’s quoted price sits in the lower half of its reported 52-week range, 45.44% below the high.
€8.80-€0.07 (-0.79%)
Nexstim Plc’s quoted price sits in the lower half of its reported 52-week range, 42.67% below the high.
€0.80+€0.15 (+22.48%)
Nanoform Finland Oyj’s quoted price sits in the lower half of its reported 52-week range, 34.98% below the high.
€1.01-€0.01 (-0.99%)
Modulight Oyj’s quoted price sits in the lower half of its reported 52-week range, 27.17% below the high.
€2.11-€0.04 (-1.86%)
Biohit Oyj’s quoted price sits in the lower half of its reported 52-week range, 44.18% below the high.
€1.18-€0.02 (-1.67%)
Herantis Pharma Oyj’s quoted price sits in the lower half of its reported 52-week range, 58.89% below the high.
€1.41+€0.04 (+3.07%)
Optomed Oyj’s quoted price sits in the lower half of its reported 52-week range, 67.44% below the high.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
